Industry Research Reports
Home > Reports > Service & Software > Global Artificial Intelligence in Biomedical Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Artificial Intelligence in Biomedical Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-07-31
Pages: 165 Pages
Report ld: 4815011
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Artificial Intelligence in Biomedical Market Size(US$)
CAGR 2025-2031
30.1%
Market Size,2031
USD 1,215
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 250 million
Market Forecast in 2031(Value)
US$ 1,215 million
CAGR
30.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Artificial Intelligence in Biomedical market is projected to grow from US$ 197 million in 2024 to US$ 1215 million by 2031, at a CAGR of 30.1% (2025-2031), driven by critical product segments and diverse end‑use applications.
Artificial Intelligence (AI) in biomedical refers to the application of AI technologies, such as machine learning, natural language processing, and computer vision, in the fields of medicine and biology. It is used to analyze complex biomedical data, assist in diagnostics, develop personalized treatment plans, discover new drugs, and improve healthcare outcomes. AI enhances the accuracy, speed, and efficiency of medical and biological research and clinical practices.
From a downstream perspective, Diagnosing Diseases accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Artificial Intelligence in Biomedical leading manufacturers including AstraZeneca, Thales Group, IBM Corp., ForeSee Medical, Atomwise, Cloud Pharmaceuticals, GNS Healthcare, Microsoft Corporation, Novartis AG, NVIDIA Corporation, etc., dominate supply; the top five capture approximately % of global revenue, with AstraZeneca leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Artificial Intelligence in Biomedical market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- AstraZeneca
- Thales Group
- IBM Corp.
- ForeSee Medical
- Atomwise
- Cloud Pharmaceuticals
- GNS Healthcare
- Microsoft Corporation
- Novartis AG
- NVIDIA Corporation
- Pfizer
- Recursion Pharmaceuticals
- XtalPi Inc
- Aidoc
- AliveCor
- GE Healthcare
- Imagen Technologies
- Vuno Inc.
- IDx Technologies Inc.
- Siemens Healthcare GmbH
- Neural Analytics
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Hardware
- Software
Segment by Application
- Diagnosing Diseases
- Developing Drugs
- Personalized Treatment
- Other
CHAPTER OUTLINE
Chapter 1: Defines the Artificial Intelligence in Biomedical study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Artificial Intelligence in Biomedical: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Artificial Intelligence in Biomedical Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Hardware
1.2.3 Software
1.3 Market Segmentation by Application
1.3.1 Global Artificial Intelligence in Biomedical Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Diagnosing Diseases
1.3.3 Developing Drugs
1.3.4 Personalized Treatment
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Artificial Intelligence in Biomedical Revenue Estimates and Forecasts 2020-2031
2.2 Global Artificial Intelligence in Biomedical Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Artificial Intelligence in Biomedical Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Artificial Intelligence in Biomedical Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Hardware Market Size by Players
3.3.2 Software Market Size by Players
3.4 Global Artificial Intelligence in Biomedical Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Artificial Intelligence in Biomedical Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Artificial Intelligence in Biomedical Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Artificial Intelligence in Biomedical Market Size by Type (2020-2031)
6.4 North America Artificial Intelligence in Biomedical Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Artificial Intelligence in Biomedical Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Artificial Intelligence in Biomedical Market Size by Type (2020-2031)
7.4 Europe Artificial Intelligence in Biomedical Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Artificial Intelligence in Biomedical Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Artificial Intelligence in Biomedical Market Size by Type (2020-2031)
8.4 Asia-Pacific Artificial Intelligence in Biomedical Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Artificial Intelligence in Biomedical Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Artificial Intelligence in Biomedical Market Size by Type (2020-2031)
9.4 Central and South America Artificial Intelligence in Biomedical Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Artificial Intelligence in Biomedical Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Artificial Intelligence in Biomedical Market Size by Type (2020-2031)
10.4 Middle East and Africa Artificial Intelligence in Biomedical Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Artificial Intelligence in Biomedical Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Artificial Intelligence in Biomedical Product Features and Attributes
11.1.4 AstraZeneca Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.1.5 AstraZeneca Artificial Intelligence in Biomedical Revenue by Product in 2024
11.1.6 AstraZeneca Artificial Intelligence in Biomedical Revenue by Application in 2024
11.1.7 AstraZeneca Artificial Intelligence in Biomedical Revenue by Geographic Area in 2024
11.1.8 AstraZeneca Artificial Intelligence in Biomedical SWOT Analysis
11.1.9 AstraZeneca Recent Developments
11.2 Thales Group
11.2.1 Thales Group Corporation Information
11.2.2 Thales Group Business Overview
11.2.3 Thales Group Artificial Intelligence in Biomedical Product Features and Attributes
11.2.4 Thales Group Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.2.5 Thales Group Artificial Intelligence in Biomedical Revenue by Product in 2024
11.2.6 Thales Group Artificial Intelligence in Biomedical Revenue by Application in 2024
11.2.7 Thales Group Artificial Intelligence in Biomedical Revenue by Geographic Area in 2024
11.2.8 Thales Group Artificial Intelligence in Biomedical SWOT Analysis
11.2.9 Thales Group Recent Developments
11.3 IBM Corp.
11.3.1 IBM Corp. Corporation Information
11.3.2 IBM Corp. Business Overview
11.3.3 IBM Corp. Artificial Intelligence in Biomedical Product Features and Attributes
11.3.4 IBM Corp. Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.3.5 IBM Corp. Artificial Intelligence in Biomedical Revenue by Product in 2024
11.3.6 IBM Corp. Artificial Intelligence in Biomedical Revenue by Application in 2024
11.3.7 IBM Corp. Artificial Intelligence in Biomedical Revenue by Geographic Area in 2024
11.3.8 IBM Corp. Artificial Intelligence in Biomedical SWOT Analysis
11.3.9 IBM Corp. Recent Developments
11.4 ForeSee Medical
11.4.1 ForeSee Medical Corporation Information
11.4.2 ForeSee Medical Business Overview
11.4.3 ForeSee Medical Artificial Intelligence in Biomedical Product Features and Attributes
11.4.4 ForeSee Medical Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.4.5 ForeSee Medical Artificial Intelligence in Biomedical Revenue by Product in 2024
11.4.6 ForeSee Medical Artificial Intelligence in Biomedical Revenue by Application in 2024
11.4.7 ForeSee Medical Artificial Intelligence in Biomedical Revenue by Geographic Area in 2024
11.4.8 ForeSee Medical Artificial Intelligence in Biomedical SWOT Analysis
11.4.9 ForeSee Medical Recent Developments
11.5 Atomwise
11.5.1 Atomwise Corporation Information
11.5.2 Atomwise Business Overview
11.5.3 Atomwise Artificial Intelligence in Biomedical Product Features and Attributes
11.5.4 Atomwise Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.5.5 Atomwise Artificial Intelligence in Biomedical Revenue by Product in 2024
11.5.6 Atomwise Artificial Intelligence in Biomedical Revenue by Application in 2024
11.5.7 Atomwise Artificial Intelligence in Biomedical Revenue by Geographic Area in 2024
11.5.8 Atomwise Artificial Intelligence in Biomedical SWOT Analysis
11.5.9 Atomwise Recent Developments
11.6 Cloud Pharmaceuticals
11.6.1 Cloud Pharmaceuticals Corporation Information
11.6.2 Cloud Pharmaceuticals Business Overview
11.6.3 Cloud Pharmaceuticals Artificial Intelligence in Biomedical Product Features and Attributes
11.6.4 Cloud Pharmaceuticals Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.6.5 Cloud Pharmaceuticals Recent Developments
11.7 GNS Healthcare
11.7.1 GNS Healthcare Corporation Information
11.7.2 GNS Healthcare Business Overview
11.7.3 GNS Healthcare Artificial Intelligence in Biomedical Product Features and Attributes
11.7.4 GNS Healthcare Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.7.5 GNS Healthcare Recent Developments
11.8 Microsoft Corporation
11.8.1 Microsoft Corporation Corporation Information
11.8.2 Microsoft Corporation Business Overview
11.8.3 Microsoft Corporation Artificial Intelligence in Biomedical Product Features and Attributes
11.8.4 Microsoft Corporation Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.8.5 Microsoft Corporation Recent Developments
11.9 Novartis AG
11.9.1 Novartis AG Corporation Information
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Artificial Intelligence in Biomedical Product Features and Attributes
11.9.4 Novartis AG Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.9.5 Novartis AG Recent Developments
11.10 NVIDIA Corporation
11.10.1 NVIDIA Corporation Corporation Information
11.10.2 NVIDIA Corporation Business Overview
11.10.3 NVIDIA Corporation Artificial Intelligence in Biomedical Product Features and Attributes
11.10.4 NVIDIA Corporation Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Pfizer
11.11.1 Pfizer Corporation Information
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Artificial Intelligence in Biomedical Product Features and Attributes
11.11.4 Pfizer Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.11.5 Pfizer Recent Developments
11.12 Recursion Pharmaceuticals
11.12.1 Recursion Pharmaceuticals Corporation Information
11.12.2 Recursion Pharmaceuticals Business Overview
11.12.3 Recursion Pharmaceuticals Artificial Intelligence in Biomedical Product Features and Attributes
11.12.4 Recursion Pharmaceuticals Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.12.5 Recursion Pharmaceuticals Recent Developments
11.13 XtalPi Inc
11.13.1 XtalPi Inc Corporation Information
11.13.2 XtalPi Inc Business Overview
11.13.3 XtalPi Inc Artificial Intelligence in Biomedical Product Features and Attributes
11.13.4 XtalPi Inc Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.13.5 XtalPi Inc Recent Developments
11.14 Aidoc
11.14.1 Aidoc Corporation Information
11.14.2 Aidoc Business Overview
11.14.3 Aidoc Artificial Intelligence in Biomedical Product Features and Attributes
11.14.4 Aidoc Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.14.5 Aidoc Recent Developments
11.15 AliveCor
11.15.1 AliveCor Corporation Information
11.15.2 AliveCor Business Overview
11.15.3 AliveCor Artificial Intelligence in Biomedical Product Features and Attributes
11.15.4 AliveCor Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.15.5 AliveCor Recent Developments
11.16 GE Healthcare
11.16.1 GE Healthcare Corporation Information
11.16.2 GE Healthcare Business Overview
11.16.3 GE Healthcare Artificial Intelligence in Biomedical Product Features and Attributes
11.16.4 GE Healthcare Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.16.5 GE Healthcare Recent Developments
11.17 Imagen Technologies
11.17.1 Imagen Technologies Corporation Information
11.17.2 Imagen Technologies Business Overview
11.17.3 Imagen Technologies Artificial Intelligence in Biomedical Product Features and Attributes
11.17.4 Imagen Technologies Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.17.5 Imagen Technologies Recent Developments
11.18 Vuno Inc.
11.18.1 Vuno Inc. Corporation Information
11.18.2 Vuno Inc. Business Overview
11.18.3 Vuno Inc. Artificial Intelligence in Biomedical Product Features and Attributes
11.18.4 Vuno Inc. Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.18.5 Vuno Inc. Recent Developments
11.19 IDx Technologies Inc.
11.19.1 IDx Technologies Inc. Corporation Information
11.19.2 IDx Technologies Inc. Business Overview
11.19.3 IDx Technologies Inc. Artificial Intelligence in Biomedical Product Features and Attributes
11.19.4 IDx Technologies Inc. Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.19.5 IDx Technologies Inc. Recent Developments
11.20 Siemens Healthcare GmbH
11.20.1 Siemens Healthcare GmbH Corporation Information
11.20.2 Siemens Healthcare GmbH Business Overview
11.20.3 Siemens Healthcare GmbH Artificial Intelligence in Biomedical Product Features and Attributes
11.20.4 Siemens Healthcare GmbH Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.20.5 Siemens Healthcare GmbH Recent Developments
11.21 Neural Analytics
11.21.1 Neural Analytics Corporation Information
11.21.2 Neural Analytics Business Overview
11.21.3 Neural Analytics Artificial Intelligence in Biomedical Product Features and Attributes
11.21.4 Neural Analytics Artificial Intelligence in Biomedical Revenue and Gross Margin (2020-2025)
11.21.5 Neural Analytics Recent Developments
12 Artificial Intelligence in BiomedicalIndustry Chain Analysis
12.1 Artificial Intelligence in Biomedical Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Artificial Intelligence in Biomedical Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Artificial Intelligence in Biomedical Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Artificial Intelligence in Biomedical Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Artificial Intelligence in Biomedical Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Artificial Intelligence in Biomedical Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Artificial Intelligence in Biomedical Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Artificial Intelligence in Biomedical Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Artificial Intelligence in Biomedical Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Artificial Intelligence in Biomedical Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Artificial Intelligence in Biomedical by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence in Biomedical as of 2024)
Table 11. Global Artificial Intelligence in Biomedical Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Artificial Intelligence in Biomedical Companies Headquarters
Table 13. Global Artificial Intelligence in Biomedical Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Artificial Intelligence in Biomedical Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Artificial Intelligence in Biomedical Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Artificial Intelligence in Biomedical Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Artificial Intelligence in Biomedical Revenue by Application (2026-2031) & (US$ Million)
Table 21. Artificial Intelligence in Biomedical High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Artificial Intelligence in Biomedical Growth Accelerators and Market Barriers
Table 25. North America Artificial Intelligence in Biomedical Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Artificial Intelligence in Biomedical Growth Accelerators and Market Barriers
Table 27. Europe Artificial Intelligence in Biomedical Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Artificial Intelligence in Biomedical Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Artificial Intelligence in Biomedical Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Artificial Intelligence in Biomedical Investment Opportunities and Key Challenges
Table 31. Central and South America Artificial Intelligence in Biomedical Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Artificial Intelligence in Biomedical Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Artificial Intelligence in Biomedical Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. AstraZeneca Corporation Information
Table 35. AstraZeneca Description and Major Businesses
Table 36. AstraZeneca Product Features and Attributes
Table 37. AstraZeneca Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. AstraZeneca Revenue Proportion by Product in 2024
Table 39. AstraZeneca Revenue Proportion by Application in 2024
Table 40. AstraZeneca Revenue Proportion by Geographic Area in 2024
Table 41. AstraZeneca Artificial Intelligence in Biomedical SWOT Analysis
Table 42. AstraZeneca Recent Developments
Table 43. Thales Group Corporation Information
Table 44. Thales Group Description and Major Businesses
Table 45. Thales Group Product Features and Attributes
Table 46. Thales Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Thales Group Revenue Proportion by Product in 2024
Table 48. Thales Group Revenue Proportion by Application in 2024
Table 49. Thales Group Revenue Proportion by Geographic Area in 2024
Table 50. Thales Group Artificial Intelligence in Biomedical SWOT Analysis
Table 51. Thales Group Recent Developments
Table 52. IBM Corp. Corporation Information
Table 53. IBM Corp. Description and Major Businesses
Table 54. IBM Corp. Product Features and Attributes
Table 55. IBM Corp. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. IBM Corp. Revenue Proportion by Product in 2024
Table 57. IBM Corp. Revenue Proportion by Application in 2024
Table 58. IBM Corp. Revenue Proportion by Geographic Area in 2024
Table 59. IBM Corp. Artificial Intelligence in Biomedical SWOT Analysis
Table 60. IBM Corp. Recent Developments
Table 61. ForeSee Medical Corporation Information
Table 62. ForeSee Medical Description and Major Businesses
Table 63. ForeSee Medical Product Features and Attributes
Table 64. ForeSee Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. ForeSee Medical Revenue Proportion by Product in 2024
Table 66. ForeSee Medical Revenue Proportion by Application in 2024
Table 67. ForeSee Medical Revenue Proportion by Geographic Area in 2024
Table 68. ForeSee Medical Artificial Intelligence in Biomedical SWOT Analysis
Table 69. ForeSee Medical Recent Developments
Table 70. Atomwise Corporation Information
Table 71. Atomwise Description and Major Businesses
Table 72. Atomwise Product Features and Attributes
Table 73. Atomwise Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Atomwise Revenue Proportion by Product in 2024
Table 75. Atomwise Revenue Proportion by Application in 2024
Table 76. Atomwise Revenue Proportion by Geographic Area in 2024
Table 77. Atomwise Artificial Intelligence in Biomedical SWOT Analysis
Table 78. Atomwise Recent Developments
Table 79. Cloud Pharmaceuticals Corporation Information
Table 80. Cloud Pharmaceuticals Description and Major Businesses
Table 81. Cloud Pharmaceuticals Product Features and Attributes
Table 82. Cloud Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Cloud Pharmaceuticals Recent Developments
Table 84. GNS Healthcare Corporation Information
Table 85. GNS Healthcare Description and Major Businesses
Table 86. GNS Healthcare Product Features and Attributes
Table 87. GNS Healthcare Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. GNS Healthcare Recent Developments
Table 89. Microsoft Corporation Corporation Information
Table 90. Microsoft Corporation Description and Major Businesses
Table 91. Microsoft Corporation Product Features and Attributes
Table 92. Microsoft Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Microsoft Corporation Recent Developments
Table 94. Novartis AG Corporation Information
Table 95. Novartis AG Description and Major Businesses
Table 96. Novartis AG Product Features and Attributes
Table 97. Novartis AG Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Novartis AG Recent Developments
Table 99. NVIDIA Corporation Corporation Information
Table 100. NVIDIA Corporation Description and Major Businesses
Table 101. NVIDIA Corporation Product Features and Attributes
Table 102. NVIDIA Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. NVIDIA Corporation Recent Developments
Table 104. Pfizer Corporation Information
Table 105. Pfizer Description and Major Businesses
Table 106. Pfizer Product Features and Attributes
Table 107. Pfizer Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Pfizer Recent Developments
Table 109. Recursion Pharmaceuticals Corporation Information
Table 110. Recursion Pharmaceuticals Description and Major Businesses
Table 111. Recursion Pharmaceuticals Product Features and Attributes
Table 112. Recursion Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Recursion Pharmaceuticals Recent Developments
Table 114. XtalPi Inc Corporation Information
Table 115. XtalPi Inc Description and Major Businesses
Table 116. XtalPi Inc Product Features and Attributes
Table 117. XtalPi Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. XtalPi Inc Recent Developments
Table 119. Aidoc Corporation Information
Table 120. Aidoc Description and Major Businesses
Table 121. Aidoc Product Features and Attributes
Table 122. Aidoc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Aidoc Recent Developments
Table 124. AliveCor Corporation Information
Table 125. AliveCor Description and Major Businesses
Table 126. AliveCor Product Features and Attributes
Table 127. AliveCor Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. AliveCor Recent Developments
Table 129. GE Healthcare Corporation Information
Table 130. GE Healthcare Description and Major Businesses
Table 131. GE Healthcare Product Features and Attributes
Table 132. GE Healthcare Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. GE Healthcare Recent Developments
Table 134. Imagen Technologies Corporation Information
Table 135. Imagen Technologies Description and Major Businesses
Table 136. Imagen Technologies Product Features and Attributes
Table 137. Imagen Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Imagen Technologies Recent Developments
Table 139. Vuno Inc. Corporation Information
Table 140. Vuno Inc. Description and Major Businesses
Table 141. Vuno Inc. Product Features and Attributes
Table 142. Vuno Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Vuno Inc. Recent Developments
Table 144. IDx Technologies Inc. Corporation Information
Table 145. IDx Technologies Inc. Description and Major Businesses
Table 146. IDx Technologies Inc. Product Features and Attributes
Table 147. IDx Technologies Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. IDx Technologies Inc. Recent Developments
Table 149. Siemens Healthcare GmbH Corporation Information
Table 150. Siemens Healthcare GmbH Description and Major Businesses
Table 151. Siemens Healthcare GmbH Product Features and Attributes
Table 152. Siemens Healthcare GmbH Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. Siemens Healthcare GmbH Recent Developments
Table 154. Neural Analytics Corporation Information
Table 155. Neural Analytics Description and Major Businesses
Table 156. Neural Analytics Product Features and Attributes
Table 157. Neural Analytics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 158. Neural Analytics Recent Developments
Table 159. Raw Materials Key Suppliers
Table 160. Distributors List
Table 161. Market Trends and Market Evolution
Table 162. Market Drivers and Opportunities
Table 163. Market Challenges, Risks, and Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Artificial Intelligence in Biomedical Product Picture
Figure 2. Global Artificial Intelligence in Biomedical Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Hardware Product Picture
Figure 4. Software Product Picture
Figure 5. Global Artificial Intelligence in Biomedical Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Diagnosing Diseases
Figure 7. Developing Drugs
Figure 8. Personalized Treatment
Figure 9. Other
Figure 10. Artificial Intelligence in Biomedical Report Years Considered
Figure 11. Global Artificial Intelligence in Biomedical Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)
Figure 13. Global Artificial Intelligence in Biomedical Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Artificial Intelligence in Biomedical Revenue Market Share by Region (2020-2031)
Figure 15. Global Artificial Intelligence in Biomedical Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Hardware Revenue Market Share by Player in 2024
Figure 18. Software Revenue Market Share by Player in 2024
Figure 19. Global Artificial Intelligence in Biomedical Revenue Market Share by Type (2020-2031)
Figure 20. Global Artificial Intelligence in Biomedical Revenue Market Share by Application (2020-2031)
Figure 21. North America Artificial Intelligence in Biomedical Revenue YoY (2020-2031) & (US$ Million)
Figure 22. North America Top 5 Players Artificial Intelligence in Biomedical Revenue (US$ Million) in 2024
Figure 23. North America Artificial Intelligence in Biomedical Revenue (US$ Million) by Type (2020 - 2031)
Figure 24. North America Artificial Intelligence in Biomedical Revenue (US$ Million) by Application (2020-2031)
Figure 25. US Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)
Figure 26. Canada Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)
Figure 27. Mexico Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)
Figure 28. Europe Artificial Intelligence in Biomedical Revenue YoY (2020-2031) & (US$ Million)
Figure 29. Europe Top 5 Players Artificial Intelligence in Biomedical Revenue (US$ Million) in 2024
Figure 30. Europe Artificial Intelligence in Biomedical Revenue (US$ Million) by Type (2020-2031)
Figure 31. Europe Artificial Intelligence in Biomedical Revenue (US$ Million) by Application (2020-2031)
Figure 32. Germany Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)
Figure 33. France Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)
Figure 34. U.K. Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)
Figure 35. Italy Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)
Figure 36. Russia Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Artificial Intelligence in Biomedical Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Top 8 Players Artificial Intelligence in Biomedical Revenue (US$ Million) in 2024
Figure 39. Asia-Pacific Artificial Intelligence in Biomedical Revenue (US$ Million) by Type (2020-2031)
Figure 40. Asia-Pacific Artificial Intelligence in Biomedical Revenue (US$ Million) by Application (2020-2031)
Figure 41. Indonesia Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)
Figure 42. Japan Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)
Figure 43. South Korea Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)
Figure 44. Australia Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)
Figure 45. India Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)
Figure 46. Indonesia Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)
Figure 47. Vietnam Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)
Figure 48. Malaysia Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)
Figure 49. Philippines Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)
Figure 50. Singapore Artificial Intelligence in Biomedical Revenue (2020-2031) & (US$ Million)
Figure 51. Central and South America Artificial Intelligence in Biomedical Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Central and South America Top 5 Players Artificial Intelligence in Biomedical Revenue (US$ Million) in 2024
Figure 53. Central and South America Artificial Intelligence in Biomedical Revenue (US$ Million) by Type (2020-2031)
Figure 54. Central and South America Artificial Intelligence in Biomedical Revenue (US$ Million) by Application (2020-2031)
Figure 55. Brazil Artificial Intelligence in Biomedical Revenue (2020-2025) & (US$ Million)
Figure 56. Argentina Artificial Intelligence in Biomedical Revenue (2020-2025) & (US$ Million)
Figure 57. Middle East and Africa Artificial Intelligence in Biomedical Revenue YoY (2020-2031) & (US$ Million)
Figure 58. Middle East and Africa Top 5 Players Artificial Intelligence in Biomedical Revenue (US$ Million) in 2024
Figure 59. South America Artificial Intelligence in Biomedical Revenue (US$ Million) by Type (2020-2031)
Figure 60. Middle East and Africa Artificial Intelligence in Biomedical Revenue (US$ Million) by Application (2020-2031)
Figure 61. GCC Countries Artificial Intelligence in Biomedical Revenue (2020-2025) & (US$ Million)
Figure 62. Israel Artificial Intelligence in Biomedical Revenue (2020-2025) & (US$ Million)
Figure 63. Egypt Artificial Intelligence in Biomedical Revenue (2020-2025) & (US$ Million)
Figure 64. South Africa Artificial Intelligence in Biomedical Revenue (2020-2025) & (US$ Million)
Figure 65. Artificial Intelligence in Biomedical Industry Chain Mapping
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Artificial Intelligence in Biomedical market?
The top companies in the global Artificial Intelligence in Biomedical market are AstraZeneca、Thales Group、IBM Corp..
What was the global market size of Artificial Intelligence in Biomedical in 2025?
What is the annual compound growth rate of the global Artificial Intelligence in Biomedical market size from 2025 to 2031?
What was the global market size of Artificial Intelligence in Biomedical in 2031?
Which region is expected to have the highest market share?
Related Reports
Global Artificial Intelligence in Biomedical Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Artificial Intelligence in Biomedical market is projected to grow from US$ 250 million in 2025 to US$ 1545 million by 2032, at a CAGR of 30.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-24
Pages: 175
USD 4900.00
(Single User License)
Global Artificial Intelligence in Biomedical Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Artificial Intelligence in Biomedical market size was US$ 250 million in 2025 and is forecast to reach a readjusted size of US$ 1545 million by 2032 with a CAGR of 30.1% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 118
USD 4250.00
(Single User License)
Artificial Intelligence in Biomedical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Artificial Intelligence in Biomedical was estimated to be worth US$ 250 million in 2025 and is projected to reach US$ 1545 million, growing at a CAGR of 30.1% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 143
USD 3950.00
(Single User License)
Global Artificial Intelligence in Biomedical Market Research Report 2026
The global Artificial Intelligence in Biomedical market was valued at US$ 250 million in 2025 and is anticipated to reach US$ 1545 million by 2032, at a CAGR of 30.1% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 160
USD 2900.00
(Single User License)
Global Artificial Intelligence in Biomedical Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Artificial Intelligence in Biomedical market size was US$ 197 million in 2024 and is forecast to a readjusted size of US$ 1215 million by 2031 with a CAGR of 30.1% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 111
USD 4250.00
(Single User License)
Artificial Intelligence in Biomedical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Artificial Intelligence in Biomedical was estimated to be worth US$ 197 million in 2024 and is forecast to a readjusted size of US$ 1215 million by 2031 with a CAGR of 30.1% during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 146
USD 3950.00
(Single User License)
Global Artificial Intelligence in Biomedical Market Research Report 2025
The global market for Artificial Intelligence in Biomedical was valued at US$ 197 million in the year 2024 and is projected to reach a revised size of US$ 1215 million by 2031, growing at a CAGR of 30.1% during the forecast period.
Published Date: 2025-03-12
Pages: 102
USD 2900.00
(Single User License)
Global and United States Artificial Intelligence in Biomedical Market Report & Forecast 2024-2030
The global Artificial Intelligence in Biomedical revenue was US$ 150 million in 2023 and is forecast to a readjusted size of US$ 956 million by 2030 with a CAGR of 30.1% during the review period (2024-2030).
Published Date: 2024-12-28
Pages: 147
USD 4350.00
(Single User License)
Global Artificial Intelligence in Biomedical Market Insights, Forecast to 2030
Valued at US$ 197 million in 2024, the global Artificial Intelligence in Biomedical market is forecast to reach US$ 956 million by 2030, at a CAGR of 30.1% during the forecast period.
Published Date: 2024-12-28
Pages: 167
USD 4900.00
(Single User License)
Artificial Intelligence in Biomedical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Artificial Intelligence in Biomedical was estimated to be worth US$ 150 million in 2023 and is forecast to a readjusted size of US$ 956 million by 2030 with a CAGR of 30.1% during the forecast period 2024-2030.
Published Date: 2024-12-28
Pages: 141
USD 3950.00
(Single User License)
Global Artificial Intelligence in Biomedical Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Artificial Intelligence in Biomedical market is projected to grow from US$ 250 million in 2025 to US$ 1545 million by 2032, at a CAGR of 30.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-24
Pages: 175
USD 4900.00 (Single User License)Global Artificial Intelligence in Biomedical Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Artificial Intelligence in Biomedical market size was US$ 250 million in 2025 and is forecast to reach a readjusted size of US$ 1545 million by 2032 with a CAGR of 30.1% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 118
USD 4250.00 (Single User License)Artificial Intelligence in Biomedical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Artificial Intelligence in Biomedical was estimated to be worth US$ 250 million in 2025 and is projected to reach US$ 1545 million, growing at a CAGR of 30.1% from 2026 to 2032.
Published: 2026-01-19
Pages: 143
USD 3950.00 (Single User License)Global Artificial Intelligence in Biomedical Market Research Report 2026
The global Artificial Intelligence in Biomedical market was valued at US$ 250 million in 2025 and is anticipated to reach US$ 1545 million by 2032, at a CAGR of 30.1% from 2026 to 2032.
Published: 2026-01-08
Pages: 160
USD 2900.00 (Single User License)Global Artificial Intelligence in Biomedical Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Artificial Intelligence in Biomedical market size was US$ 197 million in 2024 and is forecast to a readjusted size of US$ 1215 million by 2031 with a CAGR of 30.1% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 111
USD 4250.00 (Single User License)Artificial Intelligence in Biomedical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Artificial Intelligence in Biomedical was estimated to be worth US$ 197 million in 2024 and is forecast to a readjusted size of US$ 1215 million by 2031 with a CAGR of 30.1% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 146
USD 3950.00 (Single User License)Global Artificial Intelligence in Biomedical Market Research Report 2025
The global market for Artificial Intelligence in Biomedical was valued at US$ 197 million in the year 2024 and is projected to reach a revised size of US$ 1215 million by 2031, growing at a CAGR of 30.1% during the forecast period.
Published: 2025-03-12
Pages: 102
USD 2900.00 (Single User License)Global and United States Artificial Intelligence in Biomedical Market Report & Forecast 2024-2030
The global Artificial Intelligence in Biomedical revenue was US$ 150 million in 2023 and is forecast to a readjusted size of US$ 956 million by 2030 with a CAGR of 30.1% during the review period (2024-2030).
Published: 2024-12-28
Pages: 147
USD 4350.00 (Single User License)Global Artificial Intelligence in Biomedical Market Insights, Forecast to 2030
Valued at US$ 197 million in 2024, the global Artificial Intelligence in Biomedical market is forecast to reach US$ 956 million by 2030, at a CAGR of 30.1% during the forecast period.
Published: 2024-12-28
Pages: 167
USD 4900.00 (Single User License)Artificial Intelligence in Biomedical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Artificial Intelligence in Biomedical was estimated to be worth US$ 150 million in 2023 and is forecast to a readjusted size of US$ 956 million by 2030 with a CAGR of 30.1% during the forecast period 2024-2030.
Published: 2024-12-28
Pages: 141
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now